TITAN PHARMACEUTICALS INC — Director's Dealing 2010

Oct 27, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTNP.OB)
CIK: 0000910267
Period of Report: 2010-10-13

Reporting Person: Kapp Joachim Friedrich (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-10-13	Common Stock	P	86000	$1.429	Disposed	0	Direct
2010-10-14	Common Stock	P	181188	$1.304	Disposed	0	Direct
2010-10-15	Common Stock	P	39460	$1.30	Disposed	0	Direct
2010-10-18	Common Stock	P	25987	$1.30	Disposed	0	Direct
2010-10-19	Common Stock	P	14925	$1.30	Disposed	0	Direct
2010-10-20	Common Stock	P	97700	$1.315	Disposed	0	Direct
2010-10-21	Common Stock	P	113400	$1.310	Disposed	546339	Direct